Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices 4239 

1The H.8 release is available on the Board’s 

website, http://www.federalreserve.gov/releases/h8/ 

current/default.htm. 

Final Approval Under OMB Delegated 

Authority of the Extension for Three 

Years, With Revision, of the Following 

Information Collection 

Report title: Weekly Report of 

Selected Assets and Liabilities of 

Domestically Chartered Commercial 

Banks and U.S. Branches and Agencies 

of Foreign Banks. 

Agency form number: FR 2644. 

OMB control number: 7100–0075. 

Effective date: April 6, 2022. 

Frequency: Weekly. 

Respondents: Domestically chartered 

commercial banks and U.S. branches 

and agencies of foreign banks. 

Estimated number of respondents: 

850. 

Estimated average hours per response: 

2.19. 

Estimated annual burden hours: 

96,798. 

General description of report: The FR 

2644 is a balance sheet report that is 

collected as of each Wednesday from an 

authorized stratified sample of 875 

domestically chartered commercial 

banks and U.S. branches and agencies of 

foreign banks. The FR 2644 is the only 

source of high-frequency data used in 

the analysis of current banking 

developments. The FR 2644 collects 

sample data that are used to estimate 

universe levels for the entire 

commercial banking sector in 

conjunction with data from the 

quarterly commercial bank Consolidated 

Reports of Condition and Income (FFIEC 

031, FFIEC 041, and FFIEC 051; OMB 

No. 7100–0036) and the Report of Assets 

and Liabilities of U.S. Branches and 

Agencies of Foreign Banks (FFIEC 002; 

OMB No. 7100–0032) (Call Reports). 

Data from the FR 2644 and the Call 

Reports are utilized in construction of 

weekly estimates of U.S. bank credit, 

balance sheet data for the U.S. 

commercial banking sector, and sources 

and uses of banks’ funds, and to analyze 

current banking developments, 

including the monitoring of broad credit 

and funding conditions. The Board 

publishes the data in aggregate form in 

the weekly H.8 statistical release, Assets 

and Liabilities of Commercial Banks in 

the United States, which is followed 

closely by other government agencies, 

the banking industry, financial press, 

and other users.1 The H.8 release 

provides a balance sheet for the 

commercial banking industry as a whole 

as well as data disaggregated by its large 

domestic, small domestic and foreignrelated bank components. 

Legal authorization and 

confidentiality: The FR 2644 is 

authorized by section 2A of the Federal 

Reserve Act (FRA), which states that the 

Board ‘‘shall maintain long run growth 

of the monetary and credit aggregates 

commensurate with the economy’s long 

run potential to increase production, so 

as to promote effectively the goals of 

maximum employment, stable prices, 

and moderate long-term interest rates’’ 

(12 U.S.C. 225a.) and by section 11(a)(2) 

of the FRA, which authorizes the Board 

to require a depository institution to 

provide ‘‘reports of its liabilities and 

assets as the Board may determine to be 

necessary or desirable to enable the 

Board to discharge its responsibility to 

monitor and control monetary and 

credit aggregates’’ (12 U.S.C. 248(a)(2)). 

Section 7(c)(2) of the International 

Banking Act of 1978 makes U.S. 

branches and agencies of foreign banks 

subject to the reporting requirements of 

section 11(a)(2) of the FRA (12 U.S.C. 

3105(c)(2)). The FR 2644 is voluntary, 

although the Board would have the 

authority to require depository 

institutions to file these reports. 

Although the Board releases aggregate 

data derived from the FR 2644 in the 

weekly H.8 Statistical Release, 

individual bank information provided 

by each respondent is treated as 

confidential because that information 

constitutes nonpublic commercial or 

financial information, which is both 

customarily and actually treated as 

private by the respondent, and thus may 

be kept confidential by the Board 

pursuant to exemption 4 of the Freedom 

of Information Act (5 U.S.C. 552(b)(4)). 

Current actions: On October 5, 2021, 

the Board published a notice in the 

Federal Register (86 FR 54975) 

requesting public comment for 60 days 

on the extension, with revision, of the 

Weekly Report of Selected Assets and 

Liabilities of Domestically Chartered 

Commercial Banks and U.S. Branches 

and Agencies of Foreign Banks. The 

Board proposed revisions that would 

simplify and reduce the overall 

reporting requirements associated with 

the FR 2644 collection, including: (1) 

Eliminating the data items on net 

unrealized gains (losses) on availablefor-sale securities (Memoranda items 1 

and 1.a); (2) Revising the reporting 

instructions for foreign-related 

institutions pertaining to consumer 

loans and the allowance for loan and 

lease losses to bring them in line with 

these institutions’ Call Report; (3) 

Changing the reporting instructions for 

small domestically chartered 

commercial banks for loans to, and 

acceptances of, commercial banks in the 

U.S. (item 4.b); and (4) Reducing the 

authorized sample of domestically 

chartered commercial banks and U.S. 

agencies and branches of foreign banks 

from the current 875 respondents to 

850. In addition to the initial proposed 

revisions, the Board will make a 

clarifying change to item 4g of the form 

to align with the instructions. The 

comment period for this notice expired 

on December 6, 2021. The Board did not 

receive any comments. The revisions 

will be implemented as proposed. 

Board of Governors of the Federal Reserve 

System, January 24, 2022. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2022–01659 Filed 1–26–22; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL TRADE COMMISSION 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request 

AGENCY: Federal Trade Commission. 

ACTION: Notice and request for comment. 

SUMMARY: The Federal Trade 

Commission (FTC) requests that the 

Office of Management and Budget 

(OMB) extend for three years the current 

Paperwork Reduction Act (PRA) 

clearance for information collection 

requirements contained in the FTC’s 

Red Flags, Card Issuers, and Address 

Discrepancy Rules (Rules). That 

clearance expires on January 31, 2022. 

DATES: Comments must be received by 

February 28, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. The reginfo.gov web 

link is a United States Government 

website produced by OMB and the 

General Services Administration (GSA). 

Under PRA requirements, OMB’s Office 

of Information and Regulatory Affairs 

(OIRA) reviews Federal information 

collections. 

FOR FURTHER INFORMATION CONTACT: 

Whitney Moore, Attorney, Division of 

Division of Privacy and Identity 

Protection, Bureau of Consumer 

Protection, Federal Trade Commission, 

Mail Code CC–8232, 600 Pennsylvania 

Ave. NW, Washington, DC 20580, (202) 

326–2645. 

SUPPLEMENTARY INFORMATION: 


lotter on DSK11XQN23PROD with NOTICES1
4240 Federal Register / Vol. 87, No. 18 / Thursday, January 27, 2022 / Notices 

1High-risk entities include, for example, financial 

institutions within the FTC’s jurisdiction and 

utilities, motor vehicle dealerships, 

telecommunications firms, colleges and 

universities, and hospitals. 

2Low-risk entities include, for example, public 

warehouse and storage firms, nursing and 

residential care facilities, automotive equipment 

rental and leasing firms, office supplies and 

stationery stores, fuel dealers, and financial 

transaction processing firms. 

3FTC staff estimates that the Rule affects as many 

as 18,356 card issuers within the FTC’s jurisdiction. 

This includes, for example, state credit unions, 

general retail merchandise stores, colleges and 

universities, and telecoms. 

Title: Red Flags Rule, 16 CFR 681.1; 

Card Issuers Rule, 16 CFR 681.2; 

Address Discrepancy Rule, 16 CFR part 

641. 

OMB Control Number: 3084–0137. 

Type of Review: Extension of 

currently approved collection. 

Abstract: The Red Flags Rule requires 

financial institutions and certain 

creditors to develop and implement 

written Identity Theft Prevention 

Programs. The Card Issuers Rule 

requires credit and debit card issuers to 

assess the validity of notifications of 

address changes under certain 

circumstances. The Address 

Discrepancy Rule provides guidance on 

what covered users of consumer reports 

must do when they receive a notice of 

address discrepancy from a nationwide 

consumer reporting agency. 

Collectively, these three anti-identity 

theft provisions are intended to prevent 

impostors from misusing another 

person’s personal information for a 

fraudulent purpose. 

The Rules implement sections 114 

and 315 of the Fair Credit Reporting Act 

(‘‘FCRA’’), 15 U.S.C. 1681 et seq. 

Estimated Annual Burden: (397,298 

hours; $20,103,752 in labor costs). 

A. Section 114: Red Flags and Card 

Issuers Rules: 

(1) Red Flags: 

(a) Estimated Number of Respondents: 

164,591 

(i) High-Risk Entities: 99,830 1

(ii) Low-Risk Entities: 64,761 2

(b) Estimated Hours Burden: 

(i) High-Risk Entities: 342,900 hours 

(ii) Low-Risk Entities: 16,523 hours 

(2) Card Issuers Rule: 

(a) Estimated Number of Respondents: 

18,894 3

(b) Estimated Hours Burden: 20,508 

hours 

(3) Combined Labor Cost Burden: 

$19,756,412 

B. Section 315—Address Discrepancy 

Rule: 

(1) Estimated Number of 

Respondents: 44,000 

(2) Estimated Hours Burden: 17,367 

hours 

(3) Estimated Labor Cost Burden: 

$347,340 

C. Capital/Non-Labor Costs for Sections 

114 and 315 

FTC staff believes that the Rules 

impose negligible capital or other nonlabor costs, as the affected entities are 

likely to have the necessary supplies 

and/or equipment already (e.g., offices 

and computers) for the information 

collections described herein. 

Request for Comment 

On October 15, 2021, the FTC sought 

public comment on the information 

collection requirements associated with 

the Rule. 86 FR 57425. The Commission 

received no germane comments. 

Pursuant to the OMB regulations, 5 CFR 

part 1320, that implement the PRA, 44 

U.S.C. 3501 et seq., the FTC is providing 

this second opportunity for public 

comment while seeking OMB approval 

to renew the pre-existing clearance for 

the Rules. 

Your comment—including your name 

and your state—will be placed on the 

public record of this proceeding. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, such as anyone’s Social 

Security number; date of birth; driver’s 

license number or other state 

identification number, or foreign 

country equivalent; passport number; 

financial account number; or credit or 

debit card number. You are also solely 

responsible for making sure that your 

comment does not include any sensitive 

health information, such as medical 

records or other individually 

identifiable health information. In 

addition, your comment should not 

include any ‘‘trade secret or any 

commercial or financial information 

which . . . is privileged or 

confidential’’ —as provided by Section 

6(f) of the FTC Act, 15 U.S.C. 46(f), and 

FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— 

including in particular competitively 

sensitive information such as costs, 

sales statistics, inventories, formulas, 

patterns, devices, manufacturing 

processes, or customer names. 

Josephine Liu, 

Assistant General Counsel for Legal Counsel. 

[FR Doc. 2022–01539 Filed 1–26–22; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–N–3240] 

List of Bulk Drug Substances for 

Which There Is a Clinical Need Under 

Section 503B of the Federal Food, 

Drug, and Cosmetic Act 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA, the Agency or we) 

is evaluating substances that have been 

nominated for inclusion on a list of bulk 

drug substances (i.e., active 

pharmaceutical ingredients) for which 

there is a clinical need (the 503B Bulks 

List). Drug products that outsourcing 

facilities compound using bulk drug 

substances on the 503B Bulks List can 

qualify for certain exemptions from the 

Federal Food, Drug, and Cosmetic Act 

(FD&C Act) provided certain conditions 

are met. This notice identifies four bulk 

drug substances that FDA has 

considered and is including on the list 

at this time: Diphenylcyclopropenone 

(DPCP) for topical use only, glycolic 

acid for topical use only in 

concentrations up to 70 percent, squaric 

acid dibutyl ester (SADBE) for topical 

use only, and trichloroacetic acid (TCA) 

for topical use only. This notice also 

identifies eight bulk drug substances 

that FDA has considered and is not 

including on the list at this time: 

diazepam, dipyridamole, dobutamine 

hydrochloride (HCl), dopamine HCl, 

edetate calcium disodium, folic acid, 

glycopyrrolate, and sodium thiosulfate 

(except for topical administration). 

Additional bulk drug substances 

nominated by the public for inclusion 

on this list are currently under 

consideration and will be the subject of 

future notices. 

DATES: The announcement of the notice 

is published in the Federal Register on 

January 27, 2022. 

ADDRESSES: For access to the docket to 

read background documents or 

comments received, go to https://

www.regulations.gov and insert the 

docket number found in brackets in the 

heading of this notice into the ‘‘Search’’ 

box and follow the prompts, and/or go 

to the Dockets Management Staff, 5630 

Fishers Lane, Rm. 1061, Rockville, MD 

20852, 240–402–7500. 

FOR FURTHER INFORMATION CONTACT: 

Kemi Asante, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 


lotter on DSK11XQN23PROD with NOTICES1